SC
GH icon

Solstein Capital’s Guardant Health GH Stock Holding History

Solstein Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-38
Closed -$4K – 394
2021
Q4 		$4K Hold
38
– – ﹤0.01% 375
2021
Q3 		$5K Hold
38
– – ﹤0.01% 404
2021
Q2 		$5K Sell
38
-625
-94% -$84.1K 0.01% 381
2021
Q1 		$101K Buy
+663
New +$100K 0.14% 153

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Solstein Capital's GH Position: Q1 2022 in Review

Solstein Capital sold out of Guardant Health (GH) in Q1 2022, closing a stake of 38 shares — an estimated $4K sold.

Solstein Capital first reported a position in GH in Q1 2021 and held it in 4 quarters. The position peaked at $101K in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Solstein Capital reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Solstein Capital sold 38 Guardant Health shares in Q1 2022, an estimated $4K.
  • Solstein Capital first reported a position in Guardant Health in Q1 2021 and held it in 4 quarters.
  • Solstein Capital's Guardant Health position peaked at $101K in Q1 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Solstein Capital's 13F filing for Q1 2022, filed 5 May 2022.